# Intracorporeal Nanocomposites and Neurological Disorders in Fulgurates (FulgurnanoF)

> **NCT04380194** · — · COMPLETED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 27 (actual)

## Conditions studied

- Neurologic Disorder

## Interventions

- **DIAGNOSTIC_TEST:** nano-composite screening

## Key facts

- **NCT ID:** NCT04380194
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-20
- **Primary completion:** 2020-09-10
- **Final completion:** 2020-09-10
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2020-09-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04380194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04380194, "Intracorporeal Nanocomposites and Neurological Disorders in Fulgurates (FulgurnanoF)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04380194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*